HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activationSuresh Bugide, Bramanandam Manavathi|Cellular Oncology|2016Cited by 57
ALK inhibitors suppress HCC and synergize with anti-PD-1 therapy and ABT-263 in preclinical modelsSuresh Bugide, Narendra Wajapeyee|iScience|2024Cited by 2